DRIVEN BY SEVERAL BLOCKBUSTER PRODUCTS, A BURGEONING PIPELINE AND THE NEED FOR DEDICATED EXPERTISE IN A MYRIAD OF TECHNICAL NUANCES ASSOCIATED WITH BIOMOLECULES, THE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET HAS EVOLVED CONSIDERABLY Biologics represent one of the fastest growing segments of the pharmaceutical industry. This can be attributed to the rapid pace of innovation in this field, driven by the need for effective and personalized pharmacological interventions. Although biopharmaceuticals offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. This has compelled many biopharmaceutical developers to outsource various aspect of their operations to contract service providers. The biopharmaceutical contract manufacturing market is presently characterized by the presence of both niche, specialty companies, focused on early-stage development and production (preclinical and / or clinical scales), and one-stop-shops, which have, over time, acquired an extensive range of capabilities to cater to essentially all the product development and commercialization requirements of sponsors. Detailed services that are commonly offered by biopharmaceutical contract manufacturers. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/250/request-sample.html It is worth highlighting that there is a significant rise in the interest of stakeholders in biopharmaceutical contract manufacturing segment; this can be validated by the increase in partnership and funding activity within this domain. It is evident that most of the biopharmaceutical CMOs have the required capabilities to operate at all scales of operation, followed by those capable of operating at both clinical and commercial scales. Further, the growing demand for biologics has compelled the players engaged in this domain to expand their existing capabilities / capacities in order to accommodate the future needs of their clients. it is worth noting that majority of the CMOs are currently using mammalian expression systems (29%), for manufacturing of biologics, followed by those using both mammalian and microbial expression systems (26%). In addition, as mentioned earlier, innovation in this field, coupled to the development of novel fermentation technologies, has further expediated the growth of biopharmaceutical contract manufacturing segment. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/biopharmaceutical-contract-manufacturing-market/250.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035 2. 4D Bioprinting Market : Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% claims Roots Analysis With an aim to counter the increasing number of cancer cases, researchers across the globe have developed AI-based solutions for the early diagnosis of a wide range of cancer indications. Currently, various AI algorithms are being used in cancer imaging. Roots Analysis is pleased to announce the publication of its recent study, titled, “Artificial Intelligence in Oncology Market, 2022-2035.” It is worth highlighting that 26% of the players engaged in this domain are using both machine learning and deep learning technologies. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/ai-in-oncology-market/request-sample.html The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this technology over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of players engaged in the development of artificial intelligence in oncology software solutions.  Elaborate profiles of prominent players that specialize in offering artificial intelligence in oncology- based software solutions.  A competitiveness analysis of artificial intelligence in oncology- based software providers, based on supplier strength, portfolio diversity and portfolio strength.  An in-depth analysis of patents related to artificial intelligence in oncology- based software solutions, filed / granted till date.  An analysis of the partnerships that have been established in this domain, in the recent past.  A detailed analysis of various investments made by players engaged in this domain, during the period 2017-2021.  A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Cancer  Solid Malignancies  Breast Cancer  Lung Cancer  Prostate Cancer  Colorectal Cancer  Brain Tumor  Others  Type of End-User  Hospitals  Pharma Companies  Research Institutes  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Rest of the World Key companies covered in the report  Ibex Medical Analytics  Niramai  Optellum  Tempus Labs  Paige  Kheiron Medical Technologies For additional details, please visit https://www.rootsanalysis.com/reports/ai-in-oncology-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Best Digital Healthcare Companies in USA Meet the leading telemedicine companies that are transforming digital health. Maintaining your health and wellbeing is essential to your quality of life, and these businesses have created cutting-edge, online solutions for anything from convenient dental care to affordable mental health services. https://combonews.online/10-best-digital-healthcare-companies-in-usa/

Custom Antibody Market Size, Regional Outlook, Competitive Landscape, Revenue Analysis & Forecast Till 2030 Read More: https://www.emergenresearch.com/industry-report/custom-antibody-market The global custom antibody market size is expected to reach USD 984.3 Million in 2030 and register a steady revenue CAGR of 10.6% over the forecast period, according to latest analysis by Emergen Research. Steady custom antibody market revenue growth can be attributed to increasing research activities and funding from several privately held research organizations and governments of several countries.

Automated Parking System Market Size, DROT, Porter’s, PEST, Region & Country Revenue Analysis & Forecast Till 2030 Read More: https://www.emergenresearch.com/industry-report/automated-parking-system-market The global automated parking system market size was USD 1319.9 Million in 2021 and is expected to register a revenue CAGR of 15.1% during the forecast period, according to latest analysis by Emergen Research. Rising demand for sustainable parking solutions and rapid urbanization is a key factor driving market revenue growth.

Smart Transportation Market Size, Industry & Landscape Outlook, Revenue Growth Analysis to 2030 Read More: https://www.emergenresearch.com/industry-report/smart-transportation-market The global smart transportation market size was USD 103.81 Billion in 2021 and is expected to register a revenue CAGR of 10.6% during the forecast period, according to latest analysis by Emergen Research. Technological advancements to enhance customer experience is the major factor driving market revenue growth.

PRESENTLY, AROUND 80 4D BIOPRINTERS AND SMART BIOMATERIALS ARE BEING DEVELOPED BY VARIOUS INDUSTRY AND NON-INDUSTRY PLAYERS, EQUIPPED WITH THE VITAL CAPABILITIES THAT CAN BE USED ACROSS A WIDE RANGE OF APPLICATION AREAS During our research, we were able to identify close to 80 bioprinters and smart biomaterials that are in different stages of development for the treatment of various diseases. It is worth highlighting that 50% players developing 4D bioprinters have established their presence in the domain after 2012. This indicates that the market is driven by the efforts of new players, majority of which have around 10 years of experience; prominent examples include (in reverse chronological order of their year of establishment) BRIGHTER (2020), Readily3D (2020), TissueLabs (2019) and Nuclera (2013). It is worth mentioning that pre-1985, seven companies have been established; examples include (in reverse chronological order of their year of establishment) 3D Systems (1983), University of Wollongong (1975) and Rutgers University (1766). Presently, the 4D bioprinting technology is being explored for use across various application areas in the biomedical industry, leading to an increase in opportunities within this domain To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/4d-bioprinting-market/request-sample.html Further, 55% players developing smart biomaterials have entered this field before 1970. This indicates that the market is driven by the efforts of well-established players, majority of which have more than 45 years of experience; prominent examples include (in reverse chronological order of their year of establishment) University of Birmingham (1900), RWTH Aachen University (1870), University of Georgis (1785) and Harvard University (1636). It is worth mentioning that post 2014, six new companies have been established; examples include (in reverse chronological order of their year of establishment) Instituto de Nanociencia y Materiales de Aragón (2020), 4D Biomaterials (2018), NanoBio Lab (2018), 1ST GRAPHENE (2016), NanoRegMed (2016) and Grolltex (2015) Moreover, companies developing 4D bioprinters and smart biomaterials have been segregated under three categories, namely small (less than 50 employees), mid-sized (51-500 employees) and large companies (more than 500 employees). It is important to mention that, for the purpose of this analysis, information has been sourced primarily from company websites and other reliable sources, such as LinkedIn. As can be observed in the figure, polymer (58%) emerged as the most preferred type of biomaterial. This is followed by natural type of biomaterial (49%). It is worth mentioning that biomaterials offer variety of applications such as making implants / protheses and medical devices, as they have the unique ability to replace or restore the lost or impaired bodily functions. Further, 58% 4D bioprinters have already been commercialized while 42% 4D bioprinters are under development phase. Examples of some commercialized 4D bioprinters include (in alphabetical order, no selection criteria) NGB-R, Organ.Aut, Origin One and Tomolite. Moreover, laser-based technology is the most preferred (42%) type of technology used in 4D bioprinters. This can be attributed to the fact that lased-based technology utilizes a nozzle free approach. The presence of nozzle can harm the cell viability sometimes, while its absence significantly improves the same. Further, this nozzle-free approach also allows to adjust the viscosity of bioink as per the need. As can be observed in the figure, 23% polymer-based smart biomaterials and 8% smart biomaterials made of natural components have already been commercialized. While 44% polymer-based smart biomaterials and 20% smart biomaterials made of natural components are under development. Notable examples of commercialized polymer-based smart biomaterials include (in alphabetical order, no selection criteria) 4Degra resin ink, SLA Resins and Porcine collagen-based hydrogel. Further, maximum number of smart biomaterials (23%) are available in sheet form. This is followed by 14% smart biomaterials available in liquid form. Further, there are 11% smart biomaterials available in gel and versatile forms, each. Moreover, most of the smart biomaterials (28) marketed / being developed can be used in the field of tissue engineering and regenerative medicine. It is worth mentioning that 4D printed pictures of tissues are used to manufacture patient-specific tissue structures using computer-aided design (CAD), along with other digital imaging methods such as magnetic resonance imaging (MRI) and X-ray computed tomography (CT). This is followed by six smart biomaterials that can be applied in the domain of orthopedics. For additional details, please visit https://www.rootsanalysis.com/reports/4d-bioprinting-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Collagen and Gelatin - Industry Analysis, Covid-19 Impact of Market Read More: https://www.emergenresearch.com/industry-report/collagen-and-gelatin-market The global collagen & gelatin market size reached USD 4787.4 Million in 2021 and is expected to register a revenue CAGR of 5.3% during the forecast period, according to latest analysis by Emergen Research Increasing high-value funding and investments for research & development projects by leading players, growing preference of consumers toward protein-rich diet, and a rising number of surgical procedures are key factors driving market revenue growth.

Smart Appliances Market Size, Key Factors, Major Players, Growth Strategies, Trends, Forecast Till 2030 Read More: https://www.emergenresearch.com/industry-report/smart-appliances-market The global smart appliances market size was USD 32.76 Billion in 2021 and is expected to register a revenue CAGR of 17.4% during the forecast period, according to latest analysis by Emergen Research. Increasing expansion of wireless connectivity across the globe is a key factor driving market revenue growth.

Recent innovation & upcoming trends Solid State Battery Market to 2030 Read More: https://www.emergenresearch.com/industry-report/solid-state-battery-market The global Solid State Battery (SSB) market size was USD 630.5 Million in 2021 and is expected to register a revenue CAGR of 36.3% over the forecast period, according to the latest analysis by Emergen Research. Rising popularity of solid-state batteries due to their longer shelf life than conventional batteries and the rapid increase in demand for miniaturized power sources are major factors driving market revenue growth. In addition, increase in dependency on AI for battery research is further expected to drive revenue growth of the market.